Es gab 50 kürzliche Insider-Transaktionen für Revelation Biosciences, Inc. (REVB), darunter 31 Käufe und 17 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $2.5M und die gesamten Insider-Verkäufe auf $7.56M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Zygmont Chester Stanley Iii, Roper Jess, Chawla Lakhmir S. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — REVB
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-02-04 |
Zygmont Chester Stanley Iii |
Chief Financial Officer |
RSU-Steuereinbehalt |
13,100 |
$1.65 |
$21.62K |
105,348 |
| 2026-02-03 |
Roper Jess |
Director |
RSU-Steuereinbehalt |
1,591 |
$1.85 |
$2.94K |
12,828 |
| 2026-02-03 |
Chawla Lakhmir S |
Director |
RSU-Steuereinbehalt |
2,261 |
$1.85 |
$4.18K |
12,158 |
| 2026-02-03 |
Carver Jennifer |
Director |
RSU-Steuereinbehalt |
1,661 |
$1.87 |
$3.11K |
12,758 |
| 2026-02-03 |
Rolke James |
Chief Executive Officer |
RSU-Steuereinbehalt |
8,521 |
$1.86 |
$15.85K |
224,853 |
| 2026-01-08 |
Roper Jess |
Director |
RSU-Zuteilung |
41,981 |
$0.90 |
$37.78K |
57,667 |
| 2026-01-08 |
Chawla Lakhmir S |
Director |
RSU-Zuteilung |
41,981 |
$0.90 |
$37.78K |
57,667 |
| 2026-01-08 |
Carver Jennifer |
Director |
RSU-Zuteilung |
41,981 |
$0.90 |
$37.78K |
57,669 |
| 2026-01-08 |
Rolke James |
Chief Executive Officer |
RSU-Zuteilung |
532,829 |
$0.90 |
$479.55K |
933,489 |
| 2026-01-08 |
Zygmont Chester Stanley Iii |
Chief Financial Officer |
RSU-Zuteilung |
78,145 |
$0.90 |
$70.33K |
473,790 |
| 2025-10-29 |
Roper Jess |
Director |
RSU-Zuteilung |
15,625 |
$1.28 |
$20K |
15,686 |
| 2025-10-29 |
Chawla Lakhmir S |
Director |
RSU-Zuteilung |
15,625 |
$1.28 |
$20K |
15,686 |
| 2025-10-29 |
Carver Jennifer |
Director |
RSU-Zuteilung |
15,625 |
$1.28 |
$20K |
15,688 |
| 2025-10-29 |
Rolke James |
Chief Executive Officer |
RSU-Zuteilung |
390,614 |
$1.28 |
$499.99K |
400,660 |
| 2025-10-29 |
Zygmont Chester Stanley Iii |
Chief Financial Officer |
RSU-Zuteilung |
390,614 |
$1.28 |
$499.99K |
395,645 |
| 2025-02-11 |
Tidmarsh George F |
Director |
RSU-Zuteilung |
181 |
$3.87 |
$700.47 |
268 |
| 2025-02-11 |
Roper Jess |
Director |
RSU-Zuteilung |
181 |
$3.87 |
$700.47 |
183 |
| 2025-02-11 |
Chawla Lakhmir S |
Director |
RSU-Zuteilung |
181 |
$3.87 |
$700.47 |
181 |
| 2025-02-11 |
Carver Jennifer |
Director |
RSU-Zuteilung |
181 |
$3.87 |
$700.47 |
187 |
| 2025-02-11 |
Rolke James |
Chief Executive Officer |
RSU-Zuteilung |
30,095 |
$3.87 |
$116.47K |
30,137 |
| 2025-02-11 |
Zygmont Chester Stanley Iii |
Chief Financial Officer |
RSU-Zuteilung |
15,048 |
$3.87 |
$58.24K |
15,076 |
| 2023-12-08 |
Tidmarsh George F |
Director |
Informierter Verkauf |
27,771 |
$0.52 |
$14.44K |
- |
| 2023-10-16 |
Tidmarsh George F |
Director |
Informierter Verkauf |
10,957 |
$0.66 |
$7.24K |
42,096 |
| 2023-10-16 |
Tidmarsh George F |
Director |
Informierter Verkauf |
1,845 |
$0.65 |
$1.2K |
27,771 |
| 2023-09-28 |
Tidmarsh George F |
Director |
Informierter Verkauf |
1,429 |
$0.69 |
$986.01 |
42,096 |
| 2023-09-27 |
Chawla Lakhmir S |
Director |
Unbekannt |
- |
- |
- |
- |
| 2023-09-18 |
Tidmarsh George F |
Director |
Informierter Verkauf |
4,000 |
$0.74 |
$2.96K |
39,348 |
| 2023-09-15 |
Tidmarsh George F |
Director |
Informierter Verkauf |
9,500 |
$0.73 |
$6.94K |
43,348 |
| 2023-09-14 |
Tidmarsh George F |
Director |
Informierter Verkauf |
12,000 |
$0.75 |
$9K |
52,848 |
| 2023-04-18 |
Tidmarsh George F |
Director |
Informierter Kauf |
25,000 |
$1.16 |
$29K |
64,848 |
| 2023-04-17 |
Tidmarsh George F |
Director |
Informierter Kauf |
26,500 |
$1.16 |
$30.74K |
39,848 |
| 2023-04-14 |
Tidmarsh George F |
Director |
RSU-Zuteilung |
6,356 |
$1.19 |
$7.56K |
6,356 |
| 2023-04-14 |
Labelle Curt H |
Director |
RSU-Zuteilung |
6,356 |
$1.19 |
$7.56K |
6,356 |
| 2023-04-14 |
Roper Jess |
Director |
RSU-Zuteilung |
6,356 |
$1.19 |
$7.56K |
6,356 |
| 2023-04-14 |
Carver Jennifer |
Director |
RSU-Zuteilung |
6,356 |
$1.19 |
$7.56K |
6,356 |
| 2023-02-25 |
Rolke James |
Chief Executive Officer |
RSU-Zuteilung |
2,542 |
$49.00 |
$124.56K |
- |
| 2023-02-25 |
Zygmont Chester Stanley Iii |
Chief Financial Officer |
RSU-Zuteilung |
611 |
$49.00 |
$29.94K |
- |
| 2022-12-31 |
Axa Im Prime Impact Master Fund I Sca Sicav-raif |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2022-02-25 |
Tidmarsh George F |
10 Percent Owner |
Informierter Kauf |
20,000 |
$1.60 |
$32K |
467,156 |
| 2022-02-09 |
Tidmarsh George F |
10 Percent Owner |
Informierter Kauf |
30,000 |
$2.55 |
$76.6K |
447,156 |
| 2022-02-08 |
Tidmarsh George F |
10 Percent Owner |
Informierter Kauf |
1,000 |
$2.54 |
$2.54K |
417,156 |
| 2022-02-07 |
Tidmarsh George F |
10 Percent Owner |
Informierter Kauf |
42,100 |
$2.61 |
$109.78K |
1,523,335 |
| 2022-02-07 |
Tidmarsh George F |
10 Percent Owner |
Informierter Kauf |
42,100 |
$2.61 |
$109.78K |
1,523,335 |
| 2022-02-04 |
Tidmarsh George F |
10 Percent Owner |
Informierter Kauf |
7,900 |
$2.31 |
$18.26K |
1,481,235 |
| 2022-02-04 |
Tidmarsh George F |
10 Percent Owner |
Informierter Kauf |
2,000 |
$2.45 |
$4.9K |
416,156 |
| 2022-01-10 |
Feis Lawrence |
10 Percent Owner |
Sonstige (Verkauf) |
731,950 |
$10.20 |
$7.47M |
- |
| 2022-01-10 |
Tidmarsh George F |
10 Percent Owner |
Veräußerung |
21,422 |
- |
- |
- |
| 2022-01-10 |
Labelle Curt H |
Director |
Veräußerung |
21,422 |
- |
- |
- |
| 2022-01-10 |
Roper Jess |
Director |
Veräußerung |
21,422 |
- |
- |
- |
| 2022-01-10 |
Carver Jennifer |
Director |
Veräußerung |
21,422 |
- |
- |
- |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall